位置:首页 > 蛋白库 > 3BHS7_HUMAN
3BHS7_HUMAN
ID   3BHS7_HUMAN             Reviewed;         369 AA.
AC   Q9H2F3; Q96M28; Q9BSN9;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 2.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=3 beta-hydroxysteroid dehydrogenase type 7 {ECO:0000305};
DE   AltName: Full=3 beta-hydroxysteroid dehydrogenase type VII;
DE            Short=3-beta-HSD VII;
DE   AltName: Full=3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase;
DE            Short=C(27) 3-beta-HSD;
DE            EC=1.1.1.-;
DE   AltName: Full=Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase;
DE            EC=1.1.1.181 {ECO:0000269|PubMed:11067870};
GN   Name=HSD3B7 {ECO:0000312|HGNC:HGNC:18324};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INVOLVEMENT IN CBAS1,
RP   VARIANT ALA-250, AND CATALYTIC ACTIVITY.
RX   PubMed=11067870; DOI=10.1172/jci10902;
RA   Schwarz M., Wright A.C., Davis D.L., Nazer H., Bjorkhem I., Russell D.W.;
RT   "The bile acid synthetic gene 3beta-hydroxy-delta(5)-C(27)-steroid
RT   oxidoreductase is mutated in progressive intrahepatic cholestasis.";
RL   J. Clin. Invest. 106:1175-1184(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Stomach, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS CBAS1 SER-19 AND LYS-147, AND CHARACTERIZATION OF VARIANT CBAS1
RP   LYS-147.
RX   PubMed=12679481; DOI=10.1210/jc.2002-021580;
RA   Cheng J.B., Jacquemin E., Gerhardt M., Nazer H., Cresteil D., Heubi J.E.,
RA   Setchell K.D., Russell D.W.;
RT   "Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase
RT   deficiency in 16 patients with loss of bile acid synthesis and liver
RT   disease.";
RL   J. Clin. Endocrinol. Metab. 88:1833-1841(2003).
CC   -!- FUNCTION: The 3-beta-HSD enzymatic system plays a crucial role in the
CC       biosynthesis of all classes of hormonal steroids. HSD VII is active
CC       against four 7-alpha-hydroxylated sterols. Does not metabolize several
CC       different C(19/21) steroids as substrates. Involved in bile acid
CC       synthesis (PubMed:11067870). Plays a key role in cell positioning and
CC       movement in lymphoid tissues by mediating degradation of 7-alpha,25-
CC       dihydroxycholesterol (7-alpha,25-OHC): 7-alpha,25-OHC acts as a ligand
CC       for the G protein-coupled receptor GPR183/EBI2, a chemotactic receptor
CC       for a number of lymphoid cells. {ECO:0000250|UniProtKB:Q9EQC1,
CC       ECO:0000269|PubMed:11067870}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3beta-hydroxy-Delta(5)-steroid + NAD(+) = a 3-oxo-Delta(5)-
CC         steroid + H(+) + NADH; Xref=Rhea:RHEA:24076, ChEBI:CHEBI:1722,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:47907, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7alpha-hydroxycholesterol + NAD(+) = 7alpha-hydroxycholest-4-
CC         en-3-one + H(+) + NADH; Xref=Rhea:RHEA:11896, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17500, ChEBI:CHEBI:17899, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.1.1.181;
CC         Evidence={ECO:0000269|PubMed:11067870};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11897;
CC         Evidence={ECO:0000305|PubMed:11067870};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7alpha,25-dihydroxycholesterol + NAD(+) = 7alpha,25-dihydroxy-
CC         4-cholesten-3-one + H(+) + NADH; Xref=Rhea:RHEA:47156,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:37623, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:81013;
CC         Evidence={ECO:0000269|PubMed:11067870};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47157;
CC         Evidence={ECO:0000305|PubMed:11067870};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(25R)-cholest-5-en-3beta,7alpha,26-triol + NAD(+) = (25R)-
CC         7alpha,26-dihydroxycholest-4-en-3-one + H(+) + NADH;
CC         Xref=Rhea:RHEA:47180, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:76592, ChEBI:CHEBI:87476;
CC         Evidence={ECO:0000269|PubMed:11067870};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47181;
CC         Evidence={ECO:0000305|PubMed:11067870};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(24S)-7alpha-dihydroxycholesterol + NAD(+) = (24S)-7alpha,24-
CC         dihydroxycholest-4-en-3-one + H(+) + NADH; Xref=Rhea:RHEA:47200,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:37640, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:63838;
CC         Evidence={ECO:0000269|PubMed:11067870};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47201;
CC         Evidence={ECO:0000305|PubMed:11067870};
CC   -!- PATHWAY: Lipid metabolism; steroid biosynthesis.
CC       {ECO:0000269|PubMed:11067870}.
CC   -!- INTERACTION:
CC       Q9H2F3; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-3918847, EBI-10173507;
CC       Q9H2F3; O95994: AGR2; NbExp=3; IntAct=EBI-3918847, EBI-712648;
CC       Q9H2F3; Q9NYG5-2: ANAPC11; NbExp=3; IntAct=EBI-3918847, EBI-12224467;
CC       Q9H2F3; Q92624: APPBP2; NbExp=3; IntAct=EBI-3918847, EBI-743771;
CC       Q9H2F3; Q03989: ARID5A; NbExp=3; IntAct=EBI-3918847, EBI-948603;
CC       Q9H2F3; Q8WXK4-2: ASB12; NbExp=3; IntAct=EBI-3918847, EBI-18394052;
CC       Q9H2F3; Q8WVV5: BTN2A2; NbExp=3; IntAct=EBI-3918847, EBI-8648738;
CC       Q9H2F3; Q6P5X5: C22orf39; NbExp=3; IntAct=EBI-3918847, EBI-7317823;
CC       Q9H2F3; P21964: COMT; NbExp=3; IntAct=EBI-3918847, EBI-372265;
CC       Q9H2F3; Q02930-3: CREB5; NbExp=3; IntAct=EBI-3918847, EBI-10192698;
CC       Q9H2F3; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-3918847, EBI-3867333;
CC       Q9H2F3; Q12805: EFEMP1; NbExp=3; IntAct=EBI-3918847, EBI-536772;
CC       Q9H2F3; O95967: EFEMP2; NbExp=3; IntAct=EBI-3918847, EBI-743414;
CC       Q9H2F3; Q9UHF1: EGFL7; NbExp=3; IntAct=EBI-3918847, EBI-949532;
CC       Q9H2F3; Q9GZR5: ELOVL4; NbExp=3; IntAct=EBI-3918847, EBI-18535450;
CC       Q9H2F3; Q92979: EMG1; NbExp=3; IntAct=EBI-3918847, EBI-718638;
CC       Q9H2F3; P98095: FBLN2; NbExp=3; IntAct=EBI-3918847, EBI-947973;
CC       Q9H2F3; O76003: GLRX3; NbExp=3; IntAct=EBI-3918847, EBI-374781;
CC       Q9H2F3; P49639: HOXA1; NbExp=3; IntAct=EBI-3918847, EBI-740785;
CC       Q9H2F3; Q7Z5P4: HSD17B13; NbExp=3; IntAct=EBI-3918847, EBI-18053395;
CC       Q9H2F3; O00629: KPNA4; NbExp=3; IntAct=EBI-3918847, EBI-396343;
CC       Q9H2F3; Q5T749: KPRP; NbExp=3; IntAct=EBI-3918847, EBI-10981970;
CC       Q9H2F3; Q15323: KRT31; NbExp=3; IntAct=EBI-3918847, EBI-948001;
CC       Q9H2F3; Q6A162: KRT40; NbExp=3; IntAct=EBI-3918847, EBI-10171697;
CC       Q9H2F3; O43790: KRT86; NbExp=3; IntAct=EBI-3918847, EBI-9996498;
CC       Q9H2F3; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-3918847, EBI-11749135;
CC       Q9H2F3; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-3918847, EBI-10172290;
CC       Q9H2F3; P60410: KRTAP10-8; NbExp=8; IntAct=EBI-3918847, EBI-10171774;
CC       Q9H2F3; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-3918847, EBI-10172052;
CC       Q9H2F3; Q3SY46: KRTAP13-3; NbExp=3; IntAct=EBI-3918847, EBI-10241252;
CC       Q9H2F3; Q3LHN2: KRTAP19-2; NbExp=3; IntAct=EBI-3918847, EBI-12196745;
CC       Q9H2F3; Q9BYR5: KRTAP4-2; NbExp=3; IntAct=EBI-3918847, EBI-10172511;
CC       Q9H2F3; P26371: KRTAP5-9; NbExp=3; IntAct=EBI-3918847, EBI-3958099;
CC       Q9H2F3; Q5TA78: LCE4A; NbExp=3; IntAct=EBI-3918847, EBI-10246358;
CC       Q9H2F3; Q96FE5: LINGO1; NbExp=3; IntAct=EBI-3918847, EBI-719955;
CC       Q9H2F3; A8MW99: MEI4; NbExp=3; IntAct=EBI-3918847, EBI-19944212;
CC       Q9H2F3; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-3918847, EBI-16439278;
CC       Q9H2F3; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-3918847, EBI-945833;
CC       Q9H2F3; Q92570: NR4A3; NbExp=3; IntAct=EBI-3918847, EBI-13644623;
CC       Q9H2F3; P32243-2: OTX2; NbExp=3; IntAct=EBI-3918847, EBI-9087860;
CC       Q9H2F3; P10745: RBP3; NbExp=3; IntAct=EBI-3918847, EBI-12806054;
CC       Q9H2F3; Q9H6H4: REEP4; NbExp=3; IntAct=EBI-3918847, EBI-7545592;
CC       Q9H2F3; Q9UGC6: RGS17; NbExp=3; IntAct=EBI-3918847, EBI-3918154;
CC       Q9H2F3; Q96GQ5: RUSF1; NbExp=3; IntAct=EBI-3918847, EBI-8636004;
CC       Q9H2F3; O43597: SPRY2; NbExp=3; IntAct=EBI-3918847, EBI-742487;
CC       Q9H2F3; Q9Y320: TMX2; NbExp=3; IntAct=EBI-3918847, EBI-6447886;
CC       Q9H2F3; Q8IWZ5: TRIM42; NbExp=5; IntAct=EBI-3918847, EBI-5235829;
CC       Q9H2F3; B2RXF5: ZBTB42; NbExp=3; IntAct=EBI-3918847, EBI-12287587;
CC       Q9H2F3; Q8N720: ZNF655; NbExp=3; IntAct=EBI-3918847, EBI-625509;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2F3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2F3-2; Sequence=VSP_042658;
CC   -!- DISEASE: Congenital bile acid synthesis defect 1 (CBAS1) [MIM:607765]:
CC       A primary defect in bile synthesis leading to progressive liver
CC       disease. Clinical features include neonatal jaundice, severe
CC       intrahepatic cholestasis, cirrhosis. {ECO:0000269|PubMed:11067870,
CC       ECO:0000269|PubMed:12679481}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 3-beta-HSD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF277719; AAG37824.1; -; mRNA.
DR   EMBL; AK057436; BAB71486.1; -; mRNA.
DR   EMBL; AK290950; BAF83639.1; -; mRNA.
DR   EMBL; AK292068; BAF84757.1; -; mRNA.
DR   EMBL; AC135048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471192; EAW52183.1; -; Genomic_DNA.
DR   EMBL; BC004929; AAH04929.1; -; mRNA.
DR   CCDS; CCDS10698.1; -. [Q9H2F3-1]
DR   CCDS; CCDS45466.1; -. [Q9H2F3-2]
DR   RefSeq; NP_001136249.1; NM_001142777.1. [Q9H2F3-2]
DR   RefSeq; NP_001136250.1; NM_001142778.1. [Q9H2F3-2]
DR   RefSeq; NP_079469.2; NM_025193.3. [Q9H2F3-1]
DR   RefSeq; XP_005255658.2; XM_005255601.3. [Q9H2F3-1]
DR   RefSeq; XP_011544262.1; XM_011545960.2. [Q9H2F3-1]
DR   RefSeq; XP_011544263.1; XM_011545961.1. [Q9H2F3-1]
DR   RefSeq; XP_011544264.1; XM_011545962.2. [Q9H2F3-2]
DR   RefSeq; XP_016879221.1; XM_017023732.1. [Q9H2F3-2]
DR   AlphaFoldDB; Q9H2F3; -.
DR   BioGRID; 123208; 386.
DR   IntAct; Q9H2F3; 53.
DR   STRING; 9606.ENSP00000297679; -.
DR   SwissLipids; SLP:000001321; -.
DR   iPTMnet; Q9H2F3; -.
DR   PhosphoSitePlus; Q9H2F3; -.
DR   BioMuta; HSD3B7; -.
DR   DMDM; 47605550; -.
DR   EPD; Q9H2F3; -.
DR   jPOST; Q9H2F3; -.
DR   MassIVE; Q9H2F3; -.
DR   MaxQB; Q9H2F3; -.
DR   PaxDb; Q9H2F3; -.
DR   PeptideAtlas; Q9H2F3; -.
DR   PRIDE; Q9H2F3; -.
DR   ProteomicsDB; 80538; -. [Q9H2F3-1]
DR   ProteomicsDB; 80539; -. [Q9H2F3-2]
DR   Antibodypedia; 27526; 198 antibodies from 27 providers.
DR   DNASU; 80270; -.
DR   Ensembl; ENST00000262520.10; ENSP00000262520.6; ENSG00000099377.14. [Q9H2F3-2]
DR   Ensembl; ENST00000297679.10; ENSP00000297679.5; ENSG00000099377.14. [Q9H2F3-1]
DR   GeneID; 80270; -.
DR   KEGG; hsa:80270; -.
DR   MANE-Select; ENST00000297679.10; ENSP00000297679.5; NM_025193.4; NP_079469.2.
DR   UCSC; uc002eaf.3; human. [Q9H2F3-1]
DR   CTD; 80270; -.
DR   DisGeNET; 80270; -.
DR   GeneCards; HSD3B7; -.
DR   HGNC; HGNC:18324; HSD3B7.
DR   HPA; ENSG00000099377; Tissue enriched (liver).
DR   MalaCards; HSD3B7; -.
DR   MIM; 607764; gene.
DR   MIM; 607765; phenotype.
DR   neXtProt; NX_Q9H2F3; -.
DR   OpenTargets; ENSG00000099377; -.
DR   Orphanet; 79301; Congenital bile acid synthesis defect type 1.
DR   PharmGKB; PA134940289; -.
DR   VEuPathDB; HostDB:ENSG00000099377; -.
DR   eggNOG; KOG1430; Eukaryota.
DR   GeneTree; ENSGT00940000160236; -.
DR   HOGENOM; CLU_007383_6_3_1; -.
DR   InParanoid; Q9H2F3; -.
DR   OMA; GDHFKRG; -.
DR   OrthoDB; 930591at2759; -.
DR   PhylomeDB; Q9H2F3; -.
DR   TreeFam; TF354279; -.
DR   PathwayCommons; Q9H2F3; -.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   SignaLink; Q9H2F3; -.
DR   UniPathway; UPA00062; -.
DR   BioGRID-ORCS; 80270; 9 hits in 1063 CRISPR screens.
DR   ChiTaRS; HSD3B7; human.
DR   GenomeRNAi; 80270; -.
DR   Pharos; Q9H2F3; Tbio.
DR   PRO; PR:Q9H2F3; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9H2F3; protein.
DR   Bgee; ENSG00000099377; Expressed in right lobe of liver and 111 other tissues.
DR   ExpressionAtlas; Q9H2F3; baseline and differential.
DR   Genevisible; Q9H2F3; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid droplet; IDA:HPA.
DR   GO; GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0047016; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IBA:GO_Central.
DR   GO; GO:0035754; P:B cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:UniProtKB.
DR   InterPro; IPR002225; 3Beta_OHSteriod_DH/Estase.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF01073; 3Beta_HSD; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Endoplasmic reticulum;
KW   Intrahepatic cholestasis; Lipid metabolism; Membrane; NAD; Oxidoreductase;
KW   Reference proteome; Steroidogenesis; Transmembrane; Transmembrane helix.
FT   CHAIN           1..369
FT                   /note="3 beta-hydroxysteroid dehydrogenase type 7"
FT                   /id="PRO_0000087791"
FT   TRANSMEM        289..309
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        311..331
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        159
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         163
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         178..369
FT                   /note="VRGGLPLVTCALRPTGIYGEGHQIMRDFYRQGLRLGGWLFRAIPASVEHGRV
FT                   YVGNVAWMHVLAARELEQRATLMGGQVYFCYDGSPYRSYEDFNMEFLGPCGLRLVGARP
FT                   LLPYWLLVFLAALNALLQWLLRPLVLYAPLLNPYTLAVANTTFTVSTDKAQRHFGYEPL
FT                   FSWEDSRTRTILWVQAATGSAQ -> AMLPGCTCWQPGSWSSGQP (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042658"
FT   VARIANT         19
FT                   /note="G -> S (in CBAS1)"
FT                   /evidence="ECO:0000269|PubMed:12679481"
FT                   /id="VAR_054775"
FT   VARIANT         147
FT                   /note="E -> K (in CBAS1; loss of activity;
FT                   dbSNP:rs104894518)"
FT                   /evidence="ECO:0000269|PubMed:12679481"
FT                   /id="VAR_054776"
FT   VARIANT         250
FT                   /note="T -> A (in dbSNP:rs9938550)"
FT                   /evidence="ECO:0000269|PubMed:11067870"
FT                   /id="VAR_031040"
FT   VARIANT         347
FT                   /note="L -> P (in dbSNP:rs34212827)"
FT                   /id="VAR_048100"
FT   CONFLICT        265
FT                   /note="Y -> H (in Ref. 1; AAG37824)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        329
FT                   /note="T -> A (in Ref. 1; AAG37824)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   369 AA;  41016 MW;  7254A5DAAFAC23E7 CRC64;
     MADSAQAQKL VYLVTGGCGF LGEHVVRMLL QREPRLGELR VFDQHLGPWL EELKTGPVRV
     TAIQGDVTQA HEVAAAVAGA HVVIHTAGLV DVFGRASPKT IHEVNVQGTR NVIEACVQTG
     TRFLVYTSSM EVVGPNTKGH PFYRGNEDTP YEAVHRHPYP CSKALAEWLV LEANGRKVRG
     GLPLVTCALR PTGIYGEGHQ IMRDFYRQGL RLGGWLFRAI PASVEHGRVY VGNVAWMHVL
     AARELEQRAT LMGGQVYFCY DGSPYRSYED FNMEFLGPCG LRLVGARPLL PYWLLVFLAA
     LNALLQWLLR PLVLYAPLLN PYTLAVANTT FTVSTDKAQR HFGYEPLFSW EDSRTRTILW
     VQAATGSAQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024